Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

Less-invasive surfactant administration for neonatal respiratory distress syndrome: a consensus guideline

<p><strong>Introduction:</strong> Less-invasive surfactant administration (LISA) is a method of surfactant delivery to preterm infants for treating respiratory distress syndrome (RDS), which can reduce the composite risk of death or bronchopulmonary dysplasia and the time on mechan...

ver descrição completa

Detalhes bibliográficos
Main Authors:	Reynolds, P, Bustani, P, Darby, C, Fernandez Alvarez, JR, Fox, G, Jones, S, Robertson, SJ, Vasu, V, Roehr, CC
Formato:	Journal article
Idioma:	English
Publicado em:	Karger Publishers 2021

Registos relacionados

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress
Por: Ramaswamy, VV, et al.
Publicado em: (2021)

Addressing the lack of clarity about administering surfactant in preterm infants with respiratory distress syndrome treated with noninvasive respiratory support
Por: Ramaswamy, VV, et al.
Publicado em: (2021)

To sedate or not to sedate for less invasive surfactant administration: an ethical approach
Por: Peterson, J, et al.
Publicado em: (2021)

Curriculum and assessment tool for less invasive surfactant administration: an international Delphi consensus study
Por: Breindahl, N, et al.
Publicado em: (2023)

Guidelines for the use of lung ultrasound to optimise the management of neonatal respiratory distress: international expert consensus
Por: Jing Liu, et al.
Publicado em: (2025-02-01)

Efficacy of non‐invasive respiratory support modes for primary respiratory support in preterm neonates with Respiratory Distress Syndrome: Systematic review and network meta‐analysis
Por: Ramaswamy, VV, et al.
Publicado em: (2020)

Surfactant Apoprotein D in Preterm Neonates with Acute Respiratory Distress Syndrome
Por: S. A. Perepelitsa, et al.
Publicado em: (2009-10-01)

The Effects of Antenatal Corticosteroids and Surfactant Replacement on Neonatal Respiratory Distress Syndrome
Por: Suada Heljić, et al.
Publicado em: (2009-08-01)

Surfactant and respiratory distress syndrome
Por: A D Milner
Publicado em: (1996-01-01)

Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress
Por: Anna Tarocco, et al.
Publicado em: (2015-01-01)

Exogenous surfactant transport through the pulmonary airways : improving surfactant replacement therapy for neonatal respiratory distress syndrome
Por: Espinosa, Frank F. (Frank Francis)
Publicado em: (2005)

Corrigendum to “Two Mutations in Surfactant Protein C Gene Associated with Neonatal Respiratory Distress”
Por: Anna Tarocco, et al.
Publicado em: (2015-01-01)

Effects of Exogenous Surfactants on the Parameters of Blood Gas Composition in Neonatal Respiratory Distress Syndrome
Por: S. A. Perepelitsa, et al.
Publicado em: (2007-06-01)

Replacement Therapy with the Surfactant Alveofact for Neonatal Respiratory Distress Syndrome: A Pilot Study
Por: S. A. Perepelitsa
Publicado em: (2014-08-01)

Management of respiratory distress syndrome in moderate/late preterm neonates: A Delphi consensus
Por: Segundo Rite Gracia, et al.
Publicado em: (2024-11-01)

Outcomes Comparison of Early versus Late Surfactant Replacement Therapy in Neonates with Respiratory Distress Syndrome
Por: Chutinun Wongkhonkaen, et al.
Publicado em: (2023-05-01)

Clinical efficacy of using pulmonary surfactant at different times in the treatment of neonatal respiratory distress syndrome
Por: ZHU Ling, et al.
Publicado em: (2023-12-01)

An uncommon cause of neonatal respiratory distress
Por: Gabriel Dimitriou, et al.
Publicado em: (2010-12-01)

Significance of surfactant proteins in respiratory distress syndrome in preterm infants
Por: İ.A. Mirzayeva, et al.
Publicado em: (2024-04-01)

Exogenous surfactant therapy in non-respiratory distress syndrome
Por: A Greenough
Publicado em: (1996-01-01)

Surfactant BL-Induced Changes in Blood Gas Composition and Acid-Base Balance In Neonatal Respiratory Distress Syndrome
Por: S. A. Perepelitsa, et al.
Publicado em: (2006-08-01)

Laryngeal Mask Airway Method for Minimally Invasive Surfactant Therapy in Neonates with Pneumothorax Complicating Respiratory Distress Syndrome
Por: Joaquim M. B. Pinheiro, et al.
Publicado em: (2025-01-01)

Sedation for less invasive surfactant administration in preterm infants: a systematic review and meta-analysis
Por: Moschino, L, et al.
Publicado em: (2022)

Surfactant as a drug carrier
Por: Sett, A, et al.
Publicado em: (2023)

Comparison of the Consequences of Intratracheal Administration of Surfactant Plus Budesonide with Surfactant alone in Preterm Infants with Respiratory Distress Syndrome
Por: Morteza Habibi, et al.
Publicado em: (2024-01-01)

Guidelines on the management of acute respiratory distress syndrome
Por: Danny Francis McAuley, et al.
Publicado em: (2019-10-01)

The Outcomes of Preterm Infants with Neonatal Respiratory Distress Syndrome Treated by Minimally Invasive Surfactant Therapy and Non-Invasive Ventilation
Por: Tzyy-Rong Huang, et al.
Publicado em: (2024-04-01)

Respiratory Distress and the Bacteria Causing Infection in the Neonates
Por: Neihaya Heikmat Zaki
Publicado em: (2012-06-01)

Early administration of the second surfactant dose in preterm infants with severe respiratory distress syndrome
Por: Nilgün Köksal, et al.
Publicado em: (2009-12-01)

Management of neonates with respiratory distress syndrome in resource-limited settings
Por: Radhika Singh, et al.
Publicado em: (2024-05-01)

INSURE method (INtubation-SURfactant-Extubation) in early and late premature neonates with respiratory distress: factors affecting the outcome and survival rate
Por: Ali Naseh, et al.
Publicado em: (2014-06-01)

Construction and evaluation of neonatal respiratory failure risk prediction model for neonatal respiratory distress syndrome
Por: Yupeng Lei, et al.
Publicado em: (2024-01-01)

Surfactant therapy in late preterm infants: respiratory distress syndrome and beyond
Por: Ozge Sürmeli-Onay, et al.
Publicado em: (2012-06-01)

Exogenous Surfactant Therapy for Pediatric Patients with Acute Respiratory Distress Syndrome
Por: James F Lewis, et al.
Publicado em: (1997-01-01)

Use of Surfactant-BL in Adult Patients with Acute Respiratory Distress Syndrome
Por: A. V. Vlasenko, et al.
Publicado em: (2005-12-01)

Surfactant Protein D Is a Biomarker of Acute Respiratory Distress Syndrome
Por: V. V. Moroz, et al.
Publicado em: (2013-08-01)

The association between sex and neonatal respiratory distress syndrome
Por: Keren Fang, et al.
Publicado em: (2024-02-01)

Influence of catheter thickness on respiratory physiology during less invasive surfactant administration in extremely preterm infants
Por: Chamindu C. Gunatilaka, et al.
Publicado em: (2024-09-01)

Pulmonary insufficiency of extreme prematurity (PIEP) and surfactant deficiency disease (SDD) – It is time to classify respiratory distress syndrome (RDS) in preterm neonates
Por: Deepti Thandaveshwara, et al.
Publicado em: (2024-04-01)

Comparing the Effects of Two Surfactant Administration Methods: Minimally Invasive Surfactant Therapy (MIST) with Intubation (INSURE) in Infants with Respiratory Distress Syndrome
Por: Hassan Boskabadi, et al.
Publicado em: (2024-10-01)